PMID- 31025910 OWN - NLM STAT- MEDLINE DCOM- 20200518 LR - 20200518 IS - 1568-5624 (Electronic) IS - 0920-5063 (Linking) VI - 30 IP - 10 DP - 2019 Jul TI - Host-guest supramolecular hydrogel based on nanoparticles: co-delivery of DOX and siBcl-2 for synergistic cancer therapy. PG - 877-893 LID - 10.1080/09205063.2019.1612602 [doi] AB - Synergistic therapy that combines drug/siRNA for the solid tumor treatment is becoming more and more popular to reduce the side effects and enhance the antitumor efficiency. Given that, a novel injectable supramolecular hydrogel mPECT(D)/GDDC-4(R)/alpha-CD(gel) (mPECT(D) represents DOX-loaded methoxy poly(ethylene glycol)-b-poly(epsilon-caprolactone-co-1,4,8-trioxa[4.6]spiro-9-un-decanone) (mPECT) nanoparticles, GDDC-4(R) represents siBcl-2-loaded PG-P(DPAx-co-DMAEMAy)-PCB (GDDC-4) complexes nanoparticles (NPs)) was prepared via the incorporation of GDDC-4/siRNA complexes NPs into the DOX-loaded mPECT NPs/alpha-CD(gel) formed by the host-guest interaction between mPEG and alpha-CD. In vitro degradation and release experiments revealed that siBcl-2 was released from mPECT(D)/GDDC-4(R)/alpha-CD(gel) in the form of GDDC-4/siBcl-2 complexes NPs with bioactivity, and the release behavior of DOX also demonstrated sustained-release property. Compared to the single treatment groups, the enhanced cytotoxicity to SKOV3 and HeLa cells of mPECT(D)/GDDC-4(R)/alpha-CD(gel) was observed in vitro. Moreover, in vivo experiments also indicated the significant antitumor effect of mPECT(D)/GDDC-4(R)/alpha-CD(gel), suggesting the remarkable synergistic therapy of DOX and siBcl-2. Therefore, this work would provide a prospective platform to co-delivery of drugs and siRNA to improve the treatment effect of solid tumor. FAU - Peng, Dan AU - Peng D AD - a Department of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education , School of Chemical Engineering and Technology, Tianjin University , Tianjin , China. FAU - Gao, Huijie AU - Gao H AD - b Tianjin Life Science Research Center and School of basic medical sciences , Tianjin Medical University , Tianjin , China. FAU - Huang, Pingsheng AU - Huang P AD - c Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering , Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China. FAU - Shi, Xiaoguang AU - Shi X AD - c Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering , Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China. FAU - Zhou, Junhui AU - Zhou J AD - a Department of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education , School of Chemical Engineering and Technology, Tianjin University , Tianjin , China. FAU - Zhang, Jianhua AU - Zhang J AD - a Department of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education , School of Chemical Engineering and Technology, Tianjin University , Tianjin , China. FAU - Dong, Anjie AU - Dong A AD - a Department of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education , School of Chemical Engineering and Technology, Tianjin University , Tianjin , China. AD - d Collaborative Innovation Center of Chemical Science and Engineering (Tianjin) , Tianjin , China. FAU - Tang, Hua AU - Tang H AD - b Tianjin Life Science Research Center and School of basic medical sciences , Tianjin Medical University , Tianjin , China. FAU - Wang, Weiwei AU - Wang W AD - c Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering , Chinese Academy of Medical Sciences and Peking Union Medical College , Tianjin , China. FAU - Deng, Liandong AU - Deng L AD - a Department of Polymer Science and Technology, Key Laboratory of Systems Bioengineering of the Ministry of Education , School of Chemical Engineering and Technology, Tianjin University , Tianjin , China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190511 PL - England TA - J Biomater Sci Polym Ed JT - Journal of biomaterials science. Polymer edition JID - 9007393 RN - 0 (Antineoplastic Agents) RN - 0 (Drug Carriers) RN - 0 (Hydrogels) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (RNA, Small Interfering) RN - 80168379AG (Doxorubicin) SB - IM MH - Animals MH - Antineoplastic Agents/*chemistry/pharmacology MH - Doxorubicin/*chemistry/pharmacology MH - Drug Carriers/*chemistry MH - HeLa Cells MH - Humans MH - Hydrogels/*chemistry MH - Mice MH - Nanoparticles/*chemistry MH - Proto-Oncogene Proteins c-bcl-2/deficiency/*genetics MH - RNA, Small Interfering/*chemistry/genetics MH - Xenograft Model Antitumor Assays OTO - NOTNLM OT - DOX OT - Supramolecular hydrogel OT - nanoparticles OT - siBcl-2 OT - synergistic therapy EDAT- 2019/04/27 06:00 MHDA- 2020/05/19 06:00 CRDT- 2019/04/27 06:00 PHST- 2019/04/27 06:00 [pubmed] PHST- 2020/05/19 06:00 [medline] PHST- 2019/04/27 06:00 [entrez] AID - 10.1080/09205063.2019.1612602 [doi] PST - ppublish SO - J Biomater Sci Polym Ed. 2019 Jul;30(10):877-893. doi: 10.1080/09205063.2019.1612602. Epub 2019 May 11.